Food and Drug Administration: Guidance for Industry: Naming of Drug Products Containing Salt Drug Substances. Center for Drug Evaluation and Research, Food and Drug Administration: Silver Spring, MD, 2015. Available at: https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm379753.pdf. Accessed on October16, 2017.
2.
McDougallDJ, HoehnsJD, FellerTT, KrienerSJ, WitryMJ: Inclusion of salt form on prescription medication labeling as a source of patient confusion: A pilot study. Pharm Pract (Granada), 14:677, 2016.
3.
United States Pharmacopeia: Monograph Naming Policy for Salt Drug Substances. In: Drug Products and Compounded Preparations, USP General Chapter [1121] Nomenclature. United States Pharmacopeial Convention, Inc, Rockville, MD. Available at: http://www.drugfuture.com/pharmacopoeia/usp32/pub/data/v32270/usp32nf27s0_c1121.html. Accessed on October16, 2017.